4//SEC Filing
INSLEY THOMAS 4
Accession 0000905718-21-001098
CIK 0001853816other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 12:40 PM ET
Size
7.6 KB
Accession
0000905718-21-001098
Insider Transaction Report
Form 4
INSLEY THOMAS
Chief Financial Officer
Transactions
- Conversion
Common Stock
2021-08-17+4,581→ 14,337 total(indirect: By Trust) - Conversion
Series 1d Preferred Stock
2021-08-17−30,910→ 0 total(indirect: By Trust)→ Common Stock (4,581 underlying)
Footnotes (2)
- [F1]The Series 1d Preferred Stock converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
- [F2]Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Dermata Therapeutics, Inc.
CIK 0001853816
Entity typeother
Related Parties
1- filerCIK 0001239545
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 12:40 PM ET
- Size
- 7.6 KB